• Heading Health

  Led · Series A · Jun 2023

  Heading Health combines evidence-based mental health care with personalized treatment plans, offering a continuum of in-network services for hard-to-treat conditions. The company provides interventional psychiatric services in its centers, including intramuscular ketamine, Spravato, and TMS, alongside psychiatry and therapy via telehealth. Founded in 2020 by co-founders Steve Levine, MD, and CEO Simon Tankel, Heading operates locations in the Austin and Dallas–Fort Worth metros. It plans further expansion in Dallas and a first location in Houston later this year. Heading intends to use new funding to scale into new markets and to invest in its care delivery and analytics platform. The company recently completed a notable financing round, signaling early-stage investor interest in its in-network, intervention-capable care model.

• Gilgamesh Pharmaceuticals

  Participated · Series B · Dec 2022

  Gilgamesh Pharmaceuticals pursues discovery and development of improved neuropsychiatric drugs, using a platform that combines neural-circuit translational methods with AI and machine learning to optimize safety, efficacy and dosing. Its pipeline includes the ibogaine-analog GM-3009 (supported by a $14 million NIDA grant), the oral NMDAR antagonist GM-1020 (completed Phase 1 SAD/MAD and progressed into Phase 2), non-hallucinogenic neuroplasticity candidates now in IND-enabling stages, and projects targeting M1/M4 receptors. In August 2025 the company completed a strategic divestiture of clinical-stage candidate GM-2505 to AbbVie for up to $1.2 billion, and it has a separate AbbVie collaboration that included a $65 million upfront payment and up to $1.95 billion in option/ milestone payments plus royalties. The company assembled a leadership team with extensive CNS drug-development experience and intends to use recent financing to fund clinical and preclinical programs and continued discovery efforts. Gilgamesh was founded in 2019 by Jonathan Sporn and Andrew Kruegel.

• Lucid Green

  Led · Series B · Apr 2022

  Lucid Green’s platform—anchored by LucidSource, LucidID, and Lucid Connect—gives cannabis brands and retailers real-time, item-level visibility that streamlines label compliance, inventory intake, and consumer transparency. Its LucidID codes now appear on more than 160 million products, with 800,000 new IDs generated each day, cementing the company as a market standard across five key U.S. states. The company reports double-digit monthly revenue growth throughout 2025 and a 4.8-star rating for its LucidID consumer app in Apple’s App Store. Adoption of Lucid Connect, the firm’s direct-to-consumer module, more than doubled this year, and consumers have redeemed over 1.25 million BudPoints for 60,000 reward items. Management says these metrics are driving profitability improvements for partners, positioning the business for continued growth into 2026. Based in New York, Lucid Green focuses on supply-chain transparency, inventory efficiency, and consumer trust within the regulated cannabis sector.

• Dutchie

  Participated · Series D · Oct 2021

  Dutchie provides software and services to cannabis dispensaries, charging a monthly fee to create and run websites and manage orders. The company says it works with over 5,000 dispensaries in North America and processed $14 billion in annualized sales for those customers. Dutchie reports 100% year-over-year growth with dispensaries and employs about 500 people across 40 U.S. states and Canada. Management plans to deploy capital to accelerate efforts to streamline dispensary operations and to expand R&D and hiring. The company has committed $100 million to R&D over the next 12 months and is scaling its team to keep up with demand. Dutchie’s growth is being driven by wider consumer adoption, health-and-wellness use cases, and more states passing friendlier cannabis regulations. Dutchie is a nearly four-year-old Bend, Oregon company that charges cannabis dispensaries a monthly fee to create and run their websites, process orders and track what needs to be prepared for pick up. The company recently acquired Greenbits and Leaflogix—ERP and POS providers—and folded their roughly 150 employees into Dutchie, effectively doubling the team to about 300 employees. Its valuation surged to $1.7 billion in this round, roughly eight times the value assigned last August after a $35 million Series B. Dutchie says it will use the new capital to develop new products, including discovery and education tools, and to begin expanding internationally. The company is benefiting from pandemic-driven online order growth, recent state-level legalization tailwinds and what it sees as a shifting federal stance toward decriminalization. CEO Ross Lipson emphasizes a retail-first, hyperlocal model even as more customers order online. Dutchie operates a subscription platform that builds and maintains dispensary websites, processes orders, manages payments and tracks items for pickup. The company added contactless payments and a curbside pickup workflow that notifies dispensaries when customers arrive and helps locate vehicles. Dutchie says it works with over 1,300 dispensaries across 32 markets, processes more than 75,000 orders a day, powers over 25% of dispensaries and handles roughly 10% of all legal cannabis sales worldwide. The business grew rapidly during the COVID-19 pandemic—reporting a roughly 600% spike in one month and an overall 700% surge in sales volume—and it scaled its technology for approximately six times the prior load. Headcount rose from 36 to 102 employees and the company aims to double the team by the end of 2021. Dutchie plans to keep online ordering and e-commerce features as core offerings as customers continue to expect them. Dutchie builds online ordering and website software for cannabis dispensaries, positioned as a Shopify-like platform focused on pickup ordering. Dispensaries pay a monthly subscription fee; Dutchie does not take transaction cuts and it does not provide delivery (dispensaries handle that). The two-year-old, 36-person company says its software is used by 450 dispensaries across 18 states and is processing roughly $140 million in gross merchandise volume. Dutchie emphasizes product and user experience for both consumers and dispensaries and provides operational support to ensure orders are ready for pickup. The company is led by brothers Ross (CEO) and Zach Lipson (chief product officer), who have prior entrepreneurial experience. Financially, Dutchie has now raised $18 million in total, including the newly closed Series A. Dutchie, founded in 2017 in Bend, Oregon, is an on-demand marijuana and cannabis delivery service that builds online ordering tools to help consumers navigate the delivery market. The product aims to replicate the choice and convenience of online food ordering for legal cannabis purchases. The company operates in Oregon, Washington and Michigan and is launching in Colorado, Nevada and California this month, working with about 100 dispensaries. In its first year Dutchie recorded $2.5 million in gross merchandise volume and it employs 14 people, many of whom work remotely. Dutchie has signed an agreement with Canopy Rivers to operate in Canada and plans aggressive rollouts across states where medical marijuana is legal and into Canada. CEO Ross Lipson says scalability is the company’s central strategy as it expands.

No current team members are available.